# Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.

> **NCT06097065** · — · RECRUITING · sponsor: **Zhujiang Hospital** · enrollment: 2860 (estimated)

## Conditions studied

- Prediabetes
- Diabetes Mellitus
- Gestational Diabetes Mellitus
- Proteomics

## Interventions

- **DIAGNOSTIC_TEST:** Oral Glucose Tolerance Test

## Key facts

- **NCT ID:** NCT06097065
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-20
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 2860 (ESTIMATED)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097065, "Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06097065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*